heiDATA

Metrics

187,706 Downloads

Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

There was an error with your search parameters. Please clear your search and try again.

1 to 10 of 56 Results

WS_data_raw_noIP_noMTID.tab Sep 8, 2021 - Subsidizing Unit Donations: Matches, Rebates, and Discounts Compared [Dataset] Tabular Data - 153.1 KB - 123 Variables, 146 Observations - UNF:6:TaPeSzVMXRNpVAWufN8Vtg==
WS_data_noIP_noMTID_panel.tab Sep 8, 2021 - Subsidizing Unit Donations: Matches, Rebates, and Discounts Compared [Dataset] Tabular Data - 308.1 KB - 112 Variables, 791 Observations - UNF:6:xi5/aAgKejro9Ofp9fOdDw==
WS_data_noIP_noMTID.tab Sep 8, 2021 - Subsidizing Unit Donations: Matches, Rebates, and Discounts Compared [Dataset] Tabular Data - 35.6 KB - 88 Variables, 113 Observations - UNF:6:k2bt5UZ4ZZlqj4UT7+EDcQ==
Vol_1_2.pdf Sep 20, 2018 - The Italian Venus revisited (Catalogue Vol. 1.2) Adobe PDF - 6.0 MB - MD5: 9e36394db40f54c35d8386ca183c3163 This volume has two parts: I Introduction and ackowledgements, Issues of compilation, Guideline to the Catalogue, Index of Artists (with multiple cross-references to alternative names or pseudonyms); Information resources, and II Catalogue. The artworks in the catalogue are cat...
Vardarli_Suppl. Table 3.xlsx Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] MS Excel Spreadsheet - 116.7 KB - MD5: 7b97c14d958dffb9cb3347b48fd10fba Suppl. Table 3. Study characteristics of randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. NSCLC, Non-small cell lung cancer; LD-SCLC, Limited...
Vardarli_Suppl. Table 2.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 363.9 KB - MD5: 7c1640658f8d06736e3dad712a927841 Suppl. Table 2. Search strategies for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors.
Vardarli_Suppl. Table 1.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 625.1 KB - MD5: 591d49eda306f69d5fd24a059d714ccc Suppl. Table 1. Checklist according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monoth...
Vardarli_Suppl Fig 22.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 72.2 KB - MD5: 0c3e0a9c165d70c9ce99c8dffde73b91 Suppl. Fig. 22. Galbraith plot for trials investigating hypothyroidism any under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.
resobe_2012LISS.tab Apr 23, 2018 - Religion, moral attitudes and economic behavior [Dataset] Tabular Data - 3.6 MB - 140 Variables, 13228 Observations - UNF:6:MuyPmqfxkF5LETTP7Zp3OA== Data Directory: DataPackage/Stata/Data
Repository Table R4 Phosphoproteomics TiO2 n2.tab Feb 6, 2020 - CDK1 couples proliferation with protein synthesis [Repository Tables R1-R4] Tabular Data - 43.3 KB - 9 Variables, 273 Observations - UNF:6:TuQsCZsNr94F55djEF3jlA== Data HeLa cells were SILAC-labeled and treated with DMSO (heavy) or Ro3306 (light, 10 µM) for 4 h. After lysis and disassembly of polysomes in low magnesium buffer, samples were mixed, and ribosomal fractions obtained by sucrose density centrifugation were subjected to Wessel-Flügge p...

WS_data_raw_noIP_noMTID.tab

Sep 8, 2021 - Subsidizing Unit Donations: Matches, Rebates, and Discounts Compared [Dataset]

Tabular Data - 153.1 KB - 123 Variables, 146 Observations -

WS_data_noIP_noMTID_panel.tab

Sep 8, 2021 - Subsidizing Unit Donations: Matches, Rebates, and Discounts Compared [Dataset]

Tabular Data - 308.1 KB - 112 Variables, 791 Observations -

WS_data_noIP_noMTID.tab

Sep 8, 2021 - Subsidizing Unit Donations: Matches, Rebates, and Discounts Compared [Dataset]

Tabular Data - 35.6 KB - 88 Variables, 113 Observations -

Vol_1_2.pdf

Sep 20, 2018 - The Italian Venus revisited (Catalogue Vol. 1.2)

Adobe PDF - 6.0 MB -

This volume has two parts: I Introduction and ackowledgements, Issues of compilation, Guideline to the Catalogue, Index of Artists (with multiple cross-references to alternative names or pseudonyms); Information resources, and II Catalogue. The artworks in the catalogue are cat...

Vardarli_Suppl. Table 3.xlsx

Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]

MS Excel Spreadsheet - 116.7 KB -

Suppl. Table 3. Study characteristics of randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. NSCLC, Non-small cell lung cancer; LD-SCLC, Limited...

Vardarli_Suppl. Table 2.pdf

Adobe PDF - 363.9 KB -

Suppl. Table 2. Search strategies for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors.

Vardarli_Suppl. Table 1.pdf

Adobe PDF - 625.1 KB -

Suppl. Table 1. Checklist according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monoth...

Vardarli_Suppl Fig 22.pdf

Adobe PDF - 72.2 KB -

Suppl. Fig. 22. Galbraith plot for trials investigating hypothyroidism any under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials.

resobe_2012LISS.tab

Apr 23, 2018 - Religion, moral attitudes and economic behavior [Dataset]

Tabular Data - 3.6 MB - 140 Variables, 13228 Observations -

Data

Directory: DataPackage/Stata/Data

Repository Table R4 Phosphoproteomics TiO2 n2.tab

Feb 6, 2020 - CDK1 couples proliferation with protein synthesis [Repository Tables R1-R4]

Tabular Data - 43.3 KB - 9 Variables, 273 Observations -

Data

HeLa cells were SILAC-labeled and treated with DMSO (heavy) or Ro3306 (light, 10 µM) for 4 h. After lysis and disassembly of polysomes in low magnesium buffer, samples were mixed, and ribosomal fractions obtained by sucrose density centrifugation were subjected to Wessel-Flügge p...

Add Data

Share Dataverse

Link Dataverse

Reset Modifications